SJD Barcelona Children’s Hospital
SJD Barcelona Children’s Hospital
Spagna, Barcellona
Solo per bambini e adolescenti (0-18 anni)
Jaume Mora Graupera
30 anni di esperienza
accreditamenti :
Clinica certificata da :
Il medico è un oncologo pediatrico premiato, specializzato in sarcomi ossei e dei tessuti molli. Come capo del Dipartimento di Ematologia Oncologica presso Sant Joan De Déu, un ospedale pediatrico leader in Europa, il medico fornisce trattamenti per neuroblastomi, gliomi, sarcomi di Ewing e tumori di Wilms.<\/p>
Formatosi negli Stati Uniti, il medico ha completato borse di studio in ematologia oncologica pediatrica e patologia molecolare del cancro pediatrico presso Weill Cornell Medicine e Memorial Sloan Kettering Cancer Center. Il medico ha scritto oltre 70 articoli e ha sviluppato un trattamento non radiativo per i gliomi del midollo spinale.<\/p>
Il medico è uno specialista esperto in ematologia oncologica pediatrica e un neurochirurgo pediatrico di spicco in Spagna. Con oltre 30 anni di esperienza pratica, il medico guida l'Unità di Ematologia e Oncologia Pediatrica presso HM Hospitales, concentrandosi su gravi malattie ematologiche e cancerose nei bambini e negli adolescenti.<\/p>
Il medico è specializzato nella diagnosi e nel trattamento dei disturbi ematologici e cancerosi, in particolare nei sistemi eritrocitario, mieloide e linfoide. Il medico serve come consulente per l'OMS e l'UNESCO ed è coinvolto in attività di insegnamento e ricerca.<\/p>
Le credenziali educative includono lauree presso l'Universidad Complutense de Madrid, l'Università di Barcellona e l'Università del Maryland.<\/p>
Il medico possiede una laurea in Medicina presso l'Università Complutense di Madrid e un dottorato presso l'Università di Barcellona. Specializzandosi in Ematologia e Oncologia Pediatrica presso l'Università del Maryland, il medico è esperto nel trattamento di tumori ossei e cerebrali, nonché di leucemia e malattie ematologiche.<\/p>
Con oltre due decenni di esperienza, il medico attualmente dirige l'Unità di Ematologia e Oncologia Pediatrica presso l'Ospedale HM Montepríncipe, concentrandosi sulla cura di bambini e adolescenti. In precedenza, il medico ha ricoperto la stessa posizione presso l'Ospedale Universitario Clínica San Rafael ed è autore di numerose pubblicazioni scientifiche.<\/p>
Il medico è un oncologo medico distinto con oltre 30 anni di esperienza, specializzato nel trattamento non chirurgico dei tumori genitourinari, inclusi i tumori della prostata, del rene e della vescica, nonché sarcomi e tumori di origine sconosciuta. Attualmente, il medico guida l'Unità Tumori Genitourinari, del Sistema Nervoso Centrale, Sarcomi e Tumori di Origine Sconosciuta presso l'Ospedale Universitario Vall d'Hebron di Barcellona ed è affiliato al Centro Medico Teknon.<\/p>
Con un dottorato in Medicina e Chirurgia, il medico ha guidato numerosi studi clinici multicentrici nazionali ed è autore di oltre 120 articoli sottoposti a revisione paritaria. Il medico è riconosciuto come uno dei principali esperti in oncologia genitourinaria in Spagna.<\/p>
Spain hosts several leading centers for Ewing's sarcoma, specializing in limb-preservation and pediatric oncology. SJD Barcelona Children's Hospital and Clínica Universidad de Navarra are primary choices. These institutions use multidisciplinary tumor boards and advanced biological reconstructions. They maintain high survival and limb-retention rates for complex bone tumors.
Bookimed Expert Insight: While SJD Barcelona is a top choice for children, adult patients often find better multidisciplinary support at Centro Médico Teknon or Quironsalud Madrid. These centers manage higher volumes of adult musculoskeletal cases and offer genomic profiling for targeted therapy. Interestingly, Bookimed data shows that centers in Barcelona like Hospital Quiron Barcelona often collaborate with American oncology institutions, providing access to international treatment protocols that may not be available in smaller regional hospitals.
Patient Consensus: Patients emphasize finding a hospital with a dedicated sarcoma team rather than a general oncology ward. They note that having pathology, imaging, and surgery coordinated in one system is vital for accurate diagnosis and timely treatment.
Leading Ewing's sarcoma specialists in Spain include Dr. Jaume Mora Graupera at SJD Barcelona Children's Hospital and Dr. Blanca Lopez Ibor at HM Hospitales. These experts operate within JCI-accredited facilities. They provide integrated care involving molecular diagnostics, chemotherapy, and limb-preserving surgery for pediatric and adult patients.
Bookimed Expert Insight: Spain's high-volume centers provide a distinct advantage for rare bone tumors. SJD Barcelona Children's Hospital performs 14,000 operations annually and houses a dedicated Molecular Medicine Laboratory. This infrastructure allows specialists to refine treatment protocols based on specific genetic markers. It often leads to higher success rates in complex limb-sparing procedures.
Patient Consensus: Patients emphasize the need for expert pathology reviews before starting any treatment. They advocate for care at major university hospitals in Madrid or Barcelona where surgery and radiation are managed together.
Standard first-line therapy for Ewing's sarcoma in Spain involves a multi-modal approach of induction chemotherapy, surgery, and radiation. Spanish oncology centers utilize European protocols, treating the condition as a systemic disease. Centers like SJD Barcelona Children's Hospital use molecular diagnostics to guide these intensive protocols.
Bookimed Expert Insight: Spanish pediatric centers show a heavy concentration of expertise in Barcelona. Dr. Jaume Mora Graupera at SJD Barcelona Children's Hospital brings specialized training from Memorial Sloan Kettering. This transatlantic experience often means Spanish protocols incorporate both leading European research and North American surgical techniques.
Patient Consensus: Patients note that chemotherapy starts immediately to treat the whole body. They found the decision between surgery or radiation depends strictly on the tumor's location.
Advanced therapies like CAR-T cell and targeted drugs are available in Spain. The country serves as a major European hub for oncology. Patients access these treatments through a network of accredited centers. Implementation relies on specific genetic profiles or clinical trial eligibility.
Bookimed Expert Insight: Spain’s unique hospital exemption model allows centers like SJD Barcelona Children's Hospital to develop academic CAR-T therapies on-site. This significantly increases availability beyond commercial drugs. Note that HLA-matching or specific molecular reports are required before specialists can confirm eligibility for these programs.
Patient Consensus: Patients emphasize that reaching a dedicated sarcoma team in Barcelona or Madrid is vital for accessing experimental options. They note that bringing complete pathology and molecular reports helps speed up the specialist review process.
Treatment for Ewing's sarcoma in Spain typically spans 6 to 12 months. This multi-phase process includes intensive chemotherapy cycles followed by local control measures like surgery or radiation. Specialized centers often perform bone resections and utilize molecular diagnostics to tailor the timeline for each case.
Bookimed Expert Insight: Spanish centers like SJD Barcelona Children's Hospital and HM Madrid specialize in highly complex pediatric cases. Data shows these institutions often use a Molecular Medicine Laboratory to refine protocols. This can adjust the treatment timeframe based on how the specific tumor responds to the first chemotherapy cycles. Patients should prioritize clinics with dedicated internal molecular labs to ensure the treatment schedule remains as efficient as possible.
Patient Consensus: Patients note that treatment is a prolonged commitment that requires clear phase-by-phase scheduling. They emphasize the importance of identifying which team coordinates the transition from chemotherapy to specialized surgery.
Spanish hospitals provide language and translation assistance through tele-translation systems and international patient departments. JCI-accredited facilities often employ multilingual coordinators for foreign patients. While most doctors speak professional English, nursing and administrative staff may have limited proficiency outside major medical hubs.
Bookimed Expert Insight: Data shows that choosing a major pediatric center like SJD Barcelona Children's Hospital is vital for Ewing's sarcoma. These high-volume institutions treat 450,000 patients annually and have more robust systems for international families than general hospitals. Their teams are accustomed to managing complex oncological communication for rare cases.
Patient Consensus: Patients note that while doctors communicate well in English, ward nurses often do not, making a bilingual advocate helpful. It is essential to confirm in advance if pathology results and consent forms can be provided in English.